Beyond the Report.
Deliver Greater Clinical Value.
Partner with Dr PreZiGen for expert interpretation, clinical context and evidence-based insights to make your genomic reports more meaningful and impactful.
Value-Added Interpretation Services
Transform raw genomic data into clinically actionable insights.
Expert Support for Complex Cases
Our specialists help interpret challenging variants, fusions and rare tumours.
Co-Branded Reports
Comprehensive, clinician-friendly reports with your lab branding.
Strengthen Your Market Position
Differentiate with expert-driven, clinically relevant reports and multidisciplinary support.
How Our Interpretation Service Works
A seamless workflow integrated with your laboratory process.
AI-Human Integrated Interpretation
Combining the power of AI with expert clinical judgement.
AI-powered
- Literature search
- Variant annotation
- Trial matching
- Pathway analysis
Expert Review
- Clinical context
- Treatment relevance
- Complex variants
- Final expert report
Comprehensive Test Types We Support
Expert interpretation across a wide range of genomic and molecular tests.
Comprehensive Genomic Profiling
Solid tumours & haematological malignancies
Targeted Gene Panels
Curated and custom panels
RNA Sequencing
Fusions, exon skipping and expression
MRD & ctDNA
Residual disease and monitoring
Biomarkers & IHC
Integrated genomic and IHC
Sample Report Preview
- Clear and concise summary
- Variant classification and clinical relevance
- Evidence-based treatment options
- Clinical trial matching
- Customisable with your lab branding
Key Benefits for Diagnostic Centres
Deliver more than data — deliver impact.
Enhanced Report Value
Attract More Referrals
Stronger Relationships with Oncologists
Expand Testing Portfolio
Improve Clinical Utility
Access to Expert Network
Stay Updated with Evidence
Marketing & Education Support
Why Partner with Dr PreZiGen?
A trusted partner for diagnostic centres and laboratories.
Specialised in Precision Oncology
Led by clinical genomics and molecular oncology experts.
Evidence-Based and Guideline-Aligned
Interpretations based on the latest NCCN, ASCO, ESMO and global guidelines.
Support for Complex and Rare Cases
Access to multidisciplinary expertise and molecular tumour boards.
Flexible Partnership Models
Interpretation services, co-branded reports, education and marketing support.
From Genomic Data to Better Patient Outcomes.
Partner with Dr PreZiGen to deliver expert interpretation and greater clinical value to your genomic reports.